Payment analysis of two diagnosis and management approaches of acute otitis media

Clinical Pediatrics

Volumn 53, Issue 9, 2014, Pages 865-873

  Casey, Janet R ^a   Pichichero, Michael E ^b  

^a Legacy Pediatrics   (United States)

^b ROCHESTER GENERAL HOSPITAL   (United States)

Author keywords

acute otitis media; antibiotics; guidelines; payment analysis; tympanostomy tubes

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFDINIR; CEFTRIAXONE; ANTIINFECTIVE AGENT;

ACUTE OTITIS MEDIA; ARTICLE; CHILD; CONTROLLED STUDY; EARDRUM; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; RECURRENT DISEASE; TYMPANOSTOMY TUBE; CASE CONTROL STUDY; COST OF ILLNESS; ECONOMICS; FEMALE; INFANT; MALE; MIDDLE EAR VENTILATION; OTITIS MEDIA; PRESCHOOL CHILD; PRIMARY HEALTH CARE;

AMOXICILLIN; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; COST OF ILLNESS; FEMALE; HUMANS; INFANT; MALE; MIDDLE EAR VENTILATION; OTITIS MEDIA; PRIMARY HEALTH CARE;

EID: 84903997936     PISSN: 00099228     EISSN: 19382707     Source Type: Journal    
DOI: 10.1177/0009922814533592     Document Type: Article

References (27)

1. Bondy J, Berman S, Glazner J, Lezotte D. Direct expenditures related to otitis media diagnoses: extrapolations from a pediatric Medicaid cohort. Pediatrics. 2000 ; 105: 1-7
2. O'Brien MA, Prosser LA, Paradise JL, et al. New vaccines against otitis media: projected benefits and cost-effectiveness. Pediatrics. 2009 ; 123: 1452-1463
3. Diagnosis and management of acute otitis media. Pediatrics. 2004 ; 113: 1451-1465
4. Lieberthal AS, Carroll AE, Chonmaitree T, et al. Diagnosis and management of acute otitis media. Pediatrics. 2013 ; 131: e964 - e999
5. Pichichero ME, Casey JR. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA. 2007 ; 298: 1772-1778
6. Casey JR, Adlowitz DG, Pichichero ME. New patterns in the otopathogens causing acute otitis media six to eight years after introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2010 ; 29: 304-309
7. Casey JR, Kaur R, Friedel V, Pichichero ME. Acute otitis media otopathogens during 2008-2010 in Rochester, NY. Pediatr Infect Dis J. 2013 ; 32: 805-809
8. Lieberman JM. Appropriate antibiotic use and why it is important: the challenges of bacterial resistance. Pediatr Infect Dis J. 2003 ; 22: 1143-1151
9. Grijalva CG, Nuorti JP, Griffin MR. Antibiotic prescription rates for acute respiratory infections in US ambulatory settings. JAMA. 2009 ; 302: 758-766
10. Pokras R, Kozak LJ, McCarthy E. Ambulatory and impatient procedures in the United States, 1994. Vital Health Stat 13. 1997 ; 132: 11-17
11. Kaleida P, Stool SE. Assessment of otoscopists' accuracy regarding middle-ear effusion. Am J Dis Child. 1992 ; 146: 433-435
12. Liebovitz E, Greenberg D, Piglansky L, et al. Recurrent acute otitis media occurring within one month from completion of antibiotic therapy: relationship to the original pathogen. Pediatr Infect Dis J. 2003 ; 22: 209-215
13. Kaur R, Casey JR, Pichichero ME. Relationship with original pathogen in recurrence of acute otitis media after completion of amoxicillin/clavulanate: bacterial relapse or new pathogen. Pediatr Infect Dis J. 2013 ; 32: 1159-1162
14. Pichichero ME, Marsocci SM, Murphy ML, Hoeger W, Francis AB, Green JL. A prospective observational study of 5-, 7-, and 10-day antibiotic treatment for acute otitis media. Otolaryngol Head Neck Surg. 2001 ; 124: 381-387
15. Healthgrades. http://www.healthgrades.com/consumer/index.cfm?fuseaction= modnw&modtype=hospitals&modact=mcc-report&copay-unknown= Unknown%20or%20N/A&coinsurance-unknown=Unknown%20or%20N/A&coinsurance= &orderitemhash=59651003CE830F4FEA50661B9CE358BA&rptsubject= Ear%20Tube%20Placement&agegroup=0009&copay=&topicid= 18&showmedicare=1&gender=B&zipcode=14534&category=procedure. Accessed April 21, 2014.
16. Martin JA, Hamilton BE, Ventura SJ, et al. Births: final data for 2009. Natl Vital Stat Rep. 2011 ; 60: 1-72
17. Powers JL, Gooch WM, Oddo LP. Comparison of the palatability of the oral suspension of cefdinir vs. amoxicillin/clavulanate potassium, cefprozil and aithromycin in pediatric patients. Pediatr Infect Dis J. 2000 ; 19: S174 - S180
18. Casey JR, Block SL, Hedrick J, Almudevar A, Pichichero ME. Comparison of amoxicillin/clavulanic acid high dose with cefdinir in the treatment of acute otitis media. Drugs. 2012 ; 72: 1991-1997
19. Leibovitz E, Piglansky L, Raiz S, Press J, Leiberman A, Dagan R. Bacteriologic and clinical efficacy of one day vs. three day intramuscular ceftriaxone for treatment of nonresponsive acute otitis media in children. Pediatr Infect Dis J. 2000 ; 19: 1040-1045
20. Pichichero ME, Casey JR, Almudevar A. Reducing the frequency of acute otitis media by individualized care. Pediatr Infect Dis J. 2013 ; 32: 473-478
21. Poehling KA, Szilagyi PG, Grijalva CG, et al. Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine. Pediatrics. 2007 ; 119: 707-715
22. Byrns PJ, Bondy J, Glazner JE, Berman S. Utilization of service for otitis media by children enrolled in Medicaid. Arch Pediatr Adolesc Med. 1997 ; 151: 407-413
23. Thompson D, Oster G, McGarry L, Klein JO. Management of otitis media among children in a large health insurance plan. Pediatr Infect Dis J. 1999 ; 18: 239-244
24. Capra M, Lieu T, Black S, Shinefield H, Martin K, Klein J. Costs of otitis media in managed care population. Pediatr Infect Dis J. 2000 ; 19: 354-355
25. Auinger P, Lanphear BP, Kalkwarf HJ, Mansour ME. Trends in Otitis Media Among Children in the United States. Pediatrics. 2003 ; 112: 514-520
26. Drug Topics Red Book: Pharmacy's Fundamental Reference. Montvale, NJ: Thomson FDR ; 2005 :
27. Ah-Tye C, Paradise JL, Colborn DK. Otorrhea in young children after tympanostomy tube placement for persistent middle ear effusion: prevalence, incidence, and duration. Pediatrics. 2001 ; 107: 1251-1258